Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
It might feel like magic when insurance picks up the tab for your prescriptions, but part of those cost savings are actually paid by your employer
customers are our success measurement
Detailed TRANSCEND-T2D-1 results will be presented at the American Diabetes Association Scientific Sessions in June and published in a peer-reviewed journal
However, these trials lasted 1252 weeks and enrolled selected populations, so rarer complications may not appear statistically significant
In addition, positive data in Nov 2024 from a phase 3 result on semaglutide will likely further broaden the available treatment landscape 4,5
US$ 26.60
US$ 26.01
US$ 28.88
